Jun Cheon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun Cheon has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Seok Ho Kang
Department of Urology, Korea University College of Medicine, Seoul, Republic of Korea
8 shared publicationsYoung Hwii Ko
Yeungnam University, College of Medicine, Daegu
8 shared publicationsJeong Gu Lee
Department of Urology, Korea University School of Medicine, Seoul, Korea
6 shared publicationsSung Gu Kang
Department of Urology, Korea University School of Medicine, Seoul, Republic of Korea
6 shared publicationsHong Seok Park
Department of Urology, Korea University School of Medicine, Seoul, Korea
5 shared publicationsJe Jong Kim
Department of Urology, Korea University School of Medicine, Seoul, Korea
5 shared publications
Latest Publications
- Open Access
- 15 July 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (28) , e29622
The effect of metabolic risk factors on urinary stone composition: An observational study
To investigate how the risk factors of metabolic diseases affect urinary stone composition, particularly uric acid (UA) stones. Overall, 583 patients with data on urinary stone composition were retrospectively analyzed and classified into UA and nonUA stone formers according to the presence of the UA component. Various factors were compared between both groups. Participants were categorized according to age, glucose level, HbA1c level, and estimated glomerular filtration rate (eGFR) into subgroups, and the incidence of UA stone was compared. Overall, 137 UA stone formers (23.5%) and 446 nonUA stone formers (76.5%) were included. Mean age and male-to-female ratio were higher in the UA group than in the nonUA group. The rates of diabetes mellitus (DM), hypertension, chronic kidney disease, and coronary artery disease, all of which were associated with differences in urinary stone composition, were higher in the UA group than in the nonUA group. The UA group exhibited lower mean eGFR and higher glucose and HbA1c levels. Similarly, the UA group had higher mean UA levels and predictably lower urinary pH. In subgroup analysis, higher age, glucose level, HbA1c level, and lower eGFR were associated with an increased risk of UA stone formation. In the multivariate logistic regression analysis, the UA group showed a significantly higher age (P < .001), DM frequency (P = .049), and HbA1c level (P = .032), but significantly lower eGFR than the nonUA group (P < .001). Age and DM were independent risk factors for UA urolithiasis, implying a relationship between urinary stone composition and metabolic diseases. Additionally, renal function and HbA1c level were risk factors for UA stones.
- 15 July 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (28) , e29622
Open AccessThe effect of metabolic risk factors on urinary stone composition: An observational study
To investigate how the risk factors of metabolic diseases affect urinary stone composition, particularly uric acid (UA) stones. Overall, 583 patients with data on urinary stone composition were retrospectively analyzed and classified into UA and nonUA stone formers according to the presence of the UA component. Various factors were compared between both groups. Participants were categorized according to age, glucose level, HbA1c level, and estimated glomerular filtration rate (eGFR) into subgroups, and the incidence of UA stone was compared. Overall, 137 UA stone formers (23.5%) and 446 nonUA stone formers (76.5%) were included. Mean age and male-to-female ratio were higher in the UA group than in the nonUA group. The rates of diabetes mellitus (DM), hypertension, chronic kidney disease, and coronary artery disease, all of which were associated with differences in urinary stone composition, were higher in the UA group than in the nonUA group. The UA group exhibited lower mean eGFR and higher glucose and HbA1c levels. Similarly, the UA group had higher mean UA levels and predictably lower urinary pH. In subgroup analysis, higher age, glucose level, HbA1c level, and lower eGFR were associated with an increased risk of UA stone formation. In the multivariate logistic regression analysis, the UA group showed a significantly higher age (P < .001), DM frequency (P = .049), and HbA1c level (P = .032), but significantly lower eGFR than the nonUA group (P < .001). Age and DM were independent risk factors for UA urolithiasis, implying a relationship between urinary stone composition and metabolic diseases. Additionally, renal function and HbA1c level were risk factors for UA stones.
- 25 March 2021
- Published by Springer Nature
- p. 1059-1072
Key Elements for Approaching Difficult Cases During Urologic Robotic Surgery
- 25 March 2021
- Published by Springer Nature
- p. 1059-1072
Key Elements for Approaching Difficult Cases During Urologic Robotic Surgery
- Open Access
- 15 June 2017
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 44
The usefulness of flexible cystoscopy for preventing double-J stent malposition after laparoscopic ureterolithotomy
The aim of this study was to evaluate the role of flexible cystoscopy in preventing malpositioning of the ureteral stent after laparoscopic ureterolithotomy in male patients. From April 2009 to June 2015, 97 male patients with stones >1.8 cm in the upper ureter underwent intracorporeal double-J stenting of the ureter after laparoscopic ureterolithotomy performed by four different surgeons. In the last 50 patients who underwent laparoscopic ureterolithotomy flexible cystoscopy was performed through the urethral route to confirm the position of the double-J stent, while in the first 47 correct positioning of the stent was confirmed through postoperative KUB. The demographic data and perioperative outcomes were reviewed retrospectively. Penalized logistic regression analysis was used to evaluate the effects of flexible cystoscopy. Upward malpositioning of the ureteral stent was found in 9 of the 47 (19.1%) patients who underwent surgery without flexible cystoscopy. Among the 50 most recent patients who underwent surgery with flexible cystoscopy through the urethral route, upward malpositioning was observed in 10 (20%) patients. The factors preventing upward malpositioning of the double-J catheter in multivariate analysis were surgeon (p = 0.039) and use of flexible cystoscopy (p = 0.008). Flexible cystoscopy is a simple, safe, quick, and effective method to identify and correct malpositioning of double-J stents, especially in male patients. This study was registered with ClinicalTrials.gov Registry on May 11, 2017 (retrospective registration) with a trial registration number of NCT03150446 .
- 15 June 2017
- Published by Springer Nature in BMC Urology
- Vol. 17 (1) , 44
Open AccessThe usefulness of flexible cystoscopy for preventing double-J stent malposition after laparoscopic ureterolithotomy
The aim of this study was to evaluate the role of flexible cystoscopy in preventing malpositioning of the ureteral stent after laparoscopic ureterolithotomy in male patients. From April 2009 to June 2015, 97 male patients with stones >1.8 cm in the upper ureter underwent intracorporeal double-J stenting of the ureter after laparoscopic ureterolithotomy performed by four different surgeons. In the last 50 patients who underwent laparoscopic ureterolithotomy flexible cystoscopy was performed through the urethral route to confirm the position of the double-J stent, while in the first 47 correct positioning of the stent was confirmed through postoperative KUB. The demographic data and perioperative outcomes were reviewed retrospectively. Penalized logistic regression analysis was used to evaluate the effects of flexible cystoscopy. Upward malpositioning of the ureteral stent was found in 9 of the 47 (19.1%) patients who underwent surgery without flexible cystoscopy. Among the 50 most recent patients who underwent surgery with flexible cystoscopy through the urethral route, upward malpositioning was observed in 10 (20%) patients. The factors preventing upward malpositioning of the double-J catheter in multivariate analysis were surgeon (p = 0.039) and use of flexible cystoscopy (p = 0.008). Flexible cystoscopy is a simple, safe, quick, and effective method to identify and correct malpositioning of double-J stents, especially in male patients. This study was registered with ClinicalTrials.gov Registry on May 11, 2017 (retrospective registration) with a trial registration number of NCT03150446 .
- 1 May 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (3) , 369-376
An Effective Repetitive Training Schedule to Achieve Skill Proficiency Using a Novel Robotic Virtual Reality Simulator
- 1 May 2015
- Published by Elsevier in Journal of Surgical Education
- Vol. 72 (3) , 369-376
An Effective Repetitive Training Schedule to Achieve Skill Proficiency Using a Novel Robotic Virtual Reality Simulator
- 1 July 2014
- Vol. 34 (7) , 3457-68
Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
According to recent studies, mTOR (mammalian target of rapamycin) inhibitor and tyrosine kinase inhibitor (TKI) can be used as combinational agents to enhance the antitumor effect or overcome resistance to one of the agents. In the present study, we investigated the synergistic interaction between NVP-BEZ235, a PI3K (phosphoinositide 3-kinase)/mTOR dual inhibitor, and sunitinib, a TKI, in castration-resistant prostate cancer (CRPC) cells with docetaxel resistance. Prostate cancer cells with different sensitivities to hormones and docetaxel levels were exposed to escalating doses of NVP-BEZ235 alone and in combination with sunitinib. The synergy between NVP-BEZ235 and sunitinib was determined by the combination index, three-dimensional model, and clonogenic assays. Flow cytometry and western blot analysis of proteins related to apoptosis and cell survival axis were performed. The combination of NVP-BEZ235 and sunitinib caused a significant synergistic antitumor effect over a wide range of doses in docetaxel-resistant CRPC cells. Furthermore, the IC50 (half-maximal inhibitory concentration) of NVP-BEZ235 and sunitinib was reduced by 7.8-fold and 6.6-fold, respectively. The three-dimensional synergy analysis resulted in a synergy volume of 182.47 μM/ml2%, indicating a strong synergistic effect of combination therapy. Combination therapy caused an induction of caspase-dependent apoptosis in docetaxel-resistant CRPC cells. Adding sunitinib did not produce any additional effect on the NVP-BEZ235-mediated inhibition of PI3K/AKT/mTOR phosphorylation. In conclusion, combining NVP-BEZ235, a dual PI3K/mTOR inhibitor, with sunitinib can synergistically potentiate the antitumor effect in CRPC cells after docetaxel failure though induction of caspase-dependent apoptosis.
- 1 July 2014
- Vol. 34 (7) , 3457-68
Synergistic antitumor effect of NVP-BEZ235 and sunitinib on docetaxel-resistant human castration-resistant prostate cancer cells.
According to recent studies, mTOR (mammalian target of rapamycin) inhibitor and tyrosine kinase inhibitor (TKI) can be used as combinational agents to enhance the antitumor effect or overcome resistance to one of the agents. In the present study, we investigated the synergistic interaction between NVP-BEZ235, a PI3K (phosphoinositide 3-kinase)/mTOR dual inhibitor, and sunitinib, a TKI, in castration-resistant prostate cancer (CRPC) cells with docetaxel resistance. Prostate cancer cells with different sensitivities to hormones and docetaxel levels were exposed to escalating doses of NVP-BEZ235 alone and in combination with sunitinib. The synergy between NVP-BEZ235 and sunitinib was determined by the combination index, three-dimensional model, and clonogenic assays. Flow cytometry and western blot analysis of proteins related to apoptosis and cell survival axis were performed. The combination of NVP-BEZ235 and sunitinib caused a significant synergistic antitumor effect over a wide range of doses in docetaxel-resistant CRPC cells. Furthermore, the IC50 (half-maximal inhibitory concentration) of NVP-BEZ235 and sunitinib was reduced by 7.8-fold and 6.6-fold, respectively. The three-dimensional synergy analysis resulted in a synergy volume of 182.47 μM/ml2%, indicating a strong synergistic effect of combination therapy. Combination therapy caused an induction of caspase-dependent apoptosis in docetaxel-resistant CRPC cells. Adding sunitinib did not produce any additional effect on the NVP-BEZ235-mediated inhibition of PI3K/AKT/mTOR phosphorylation. In conclusion, combining NVP-BEZ235, a dual PI3K/mTOR inhibitor, with sunitinib can synergistically potentiate the antitumor effect in CRPC cells after docetaxel failure though induction of caspase-dependent apoptosis.
- Open Access
- 23 May 2014
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 41
Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
The survival benefits of adrenalectomy (ADx) in the setting of metastatic cancer and prognostic factors for recurrence-free (RFS) and overall survival (OS) after adrenalectomy for metastatic carcinoma are still under debate. We evaluated the impact of clinicopathological variables on RFS and OS after ADx for metastatic carcinoma in patients with primary cancer.
- 23 May 2014
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 41
Open AccessPrognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study
The survival benefits of adrenalectomy (ADx) in the setting of metastatic cancer and prognostic factors for recurrence-free (RFS) and overall survival (OS) after adrenalectomy for metastatic carcinoma are still under debate. We evaluated the impact of clinicopathological variables on RFS and OS after ADx for metastatic carcinoma in patients with primary cancer.
- 1 June 2012
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 22 (5) , 438-442
A Study on the Learning Curve of the Robotic Virtual Reality Simulator
Purpose: A robotic virtual reality simulator (dV-Trainer™, Mimic Technologies) has been accepted as an effective training tool for the da Vinci® Surgical System (Intuitive Surgical, Inc.) in previous reports. However, there are no data available so far on how much time is required for an individual using the simulator to become proficient. We investigated how long and how many performances it takes to gain proficiency with the robotic virtual reality simulator through the learning curve. Subjects and Methods: The novice group included 20 medical students who had no previous experience. The “Tube 2” task, a program released for the dV-Trainer that imitates a vesicourethral anastomosis, was repeated more than 80 times to obtain the plateau of the learning curve. The learning curve of “Tube 2” was obtained through the S-curve trend model and cumulative sum control chart graph. Results: In the comparison of the initial and final sessions, every parameter such as mean time, collision, and critical errors was significantly improved. The repeat count for acquiring sufficient proficiency was 74 times, and the total amount of time invested for this was calculated as about 4 hours. The mean time at the plateau of the learning curve was 138 seconds. Conclusions: Our study showed that the robotic virtual reality simulator (dV-Trainer) can yield sufficient improvement in technical performance in the “Tube 2” task within 4 hours. The simulator improves the technical surgical performance, but the development of more applications to reflect actual surgical situations is needed to improve and maximize the usefulness of the simulator.
- 1 June 2012
- Published by SAGE Publications in Journal of Laparoendoscopic & Advanced Surgical Techniques
- Vol. 22 (5) , 438-442
A Study on the Learning Curve of the Robotic Virtual Reality Simulator
Purpose: A robotic virtual reality simulator (dV-Trainer™, Mimic Technologies) has been accepted as an effective training tool for the da Vinci® Surgical System (Intuitive Surgical, Inc.) in previous reports. However, there are no data available so far on how much time is required for an individual using the simulator to become proficient. We investigated how long and how many performances it takes to gain proficiency with the robotic virtual reality simulator through the learning curve. Subjects and Methods: The novice group included 20 medical students who had no previous experience. The “Tube 2” task, a program released for the dV-Trainer that imitates a vesicourethral anastomosis, was repeated more than 80 times to obtain the plateau of the learning curve. The learning curve of “Tube 2” was obtained through the S-curve trend model and cumulative sum control chart graph. Results: In the comparison of the initial and final sessions, every parameter such as mean time, collision, and critical errors was significantly improved. The repeat count for acquiring sufficient proficiency was 74 times, and the total amount of time invested for this was calculated as about 4 hours. The mean time at the plateau of the learning curve was 138 seconds. Conclusions: Our study showed that the robotic virtual reality simulator (dV-Trainer) can yield sufficient improvement in technical performance in the “Tube 2” task within 4 hours. The simulator improves the technical surgical performance, but the development of more applications to reflect actual surgical situations is needed to improve and maximize the usefulness of the simulator.
- Open Access
- 1 January 2012
- Published by XMLink in Korean Journal of Urology
- Vol. 53 (10) , 673-679
Influence of Nonregional Lymph Node Metastasis as a Prognostic Factor in Metastatic Prostate Cancer Patients
Cho S, et al. Korean J Urol. 2012 Oct;53(10):673-679. http://dx.doi.org/10.4111/kju.2012.53.10.673
- 1 January 2012
- Published by XMLink in Korean Journal of Urology
- Vol. 53 (10) , 673-679
Open AccessInfluence of Nonregional Lymph Node Metastasis as a Prognostic Factor in Metastatic Prostate Cancer Patients
Cho S, et al. Korean J Urol. 2012 Oct;53(10):673-679. http://dx.doi.org/10.4111/kju.2012.53.10.673
- Open Access
- 30 May 2011
- Published by Medknow in Asian Journal of Andrology
- Vol. 13 (5) , 724-727
Efficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.
- 30 May 2011
- Published by Medknow in Asian Journal of Andrology
- Vol. 13 (5) , 724-727
Open AccessEfficacy and cost analysis of transrectal ultrasound-guided prostate biopsy under monitored anesthesia
AJA publishes new findings in basic and clinical (including modern, traditional and epidemiological) research on Andrology.